Author Archives: Lillian

Featured Stories
Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Lawsuits Claiming NuvaRing Causes Blood Clots Continue to Build

NuvaRing is being linked to a series of thrombotic issues leading to serious health problems and litigation. The birth contol device can allegedly cause blood clots, some of which can be fatal. Manufacturers such as Merck & Co. are being … Continue reading

Posted in NuvaRing, Pharmaceuticals |

Health Concerns and Litigation over Yaz/Yasmin Birth Control

Bayer is being widely criticized over Yaz and Yasmin, two similar types of oral contraceptives. The popular birth control pills are reportedly responsible for causing blood-clots, with some instances resulting in death. In light of the evidence, advisors to the … Continue reading

Posted in Pharmaceuticals, Yaz / Yasmin |

Actos Linked to Bladder Cancer

Takeda’s Actos, the diabetes drug, has been linked to possible cases of bladder cancer. After studies established a connection between the drug and disease, the widely used medication was taken off the shelves in two European countries last June. Shortly … Continue reading

Posted in Actos, Pharmaceuticals |

Prior to Hip Implant Recall, DePuy Discussed FDA Concerns

Over the past few years, DePuy Orthopaedics has experienced several setbacks concerning their artificial hip implants. The company, which is a subsidiary of Johnson & Johnson, had recalled two of their products in September 2010 due to a high rate … Continue reading

Posted in Defective Medical Devices, Depuy, Metal Hip Implants |

Depakote Legal Troubles Not Over for Abbott

Depakote continues to pose more legal challenges for Abbott Laboratories (ABT). Among other issues, the company has allegedly violated consumer protection laws in relation to Depakote’s sale and marketing. After allegations of off-market labeling and U.S. Justice Department investigation last … Continue reading

Posted in Depakote, Pharmaceuticals |

Medtronic Spine Sales Still Steadily Dropping in Wake of Infuse Controversies

Medtronic, Inc., sales have continued to decline after months of skepticism surrounding some of their products and practices. The company is experiencing a particularly bad quarter with regards to implantable heart defibrillators and spine products, which are two of their … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

MS Drug Gilenya Under Review in Europe, but Still Deemed Safe by FDA

US medical professionals are continuing to back Novartis’ Gilenya (fingolimod) despite the growing concern following several cases of patient death in the past few months. To investigate the effects of Gilenya on one’s cardiovascular health, the European Medicines Agency (EMA) … Continue reading

Posted in Gilenya, Pharmaceuticals |